• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>Regeneron Pharmaceuticals

Regeneron Pharmaceuticals

Regeneron Pharmaceuticals Inc REGN

Last Price$515.92Day Change (%)-1.00%
Open Price$518.46Day Change ($)-5.21
Day Range513.40–522.0052-Week Range325.35–543.55

As of Fri 7/21/2017 5:15:00 PM | USD

  1. All
  2. 3rd Party
  1. UPDATE: Charting a third-quarter breakout, S&P 500 target projects to 2,500 mark

    UPDATE: Charting a third-quarter breakout, S&P 500 target projects to 2,500 mark

  2. UPDATE: Charting a third-quarter breakout, S&P -2-

    UPDATE: Charting a third-quarter breakout, S&P -2-

  3. Charting a third-quarter breakout, S&P 500 -2-

    Charting a third-quarter breakout, S&P 500 -2-

  4. Charting a third-quarter breakout, S&P 500 target projects to 2,500 mark

    Charting a third-quarter breakout, S&P 500 target projects to 2,500 mark

  5. UPDATE: Health-care fund manager with 20% gain this year sees good times ahead as FDA becomes 'more accommodating'

    UPDATE: Health-care fund manager with 20% gain this year sees good times ahead as FDA becomes 'more accommodating'

  6. UPDATE: Health-care fund manager with 20% gain this year sees good times ahead as FDA becomes 'more accommodating'

    UPDATE: Health-care fund manager with 20% gain this year sees good times ahead as FDA becomes 'more accommodating'

  7. UPDATE: Health-care fund manager with 20% gain this year sees good times ahead as FDA becomes 'more accommodating'

    UPDATE: Health-care fund manager with 20% gain this year sees good times ahead as FDA becomes 'more accommodating'

  8. UPDATE: Health-care fund manager with 20% gain this year sees good times ahead as FDA becomes 'more accommodating'

    UPDATE: Health-care fund manager with 20% gain this year sees good times ahead as FDA becomes 'more accommodating'

  9. UPDATE: Fund manager with 20% gain this year sees good times ahead as FDA becomes 'more accommodating'

    UPDATE: Fund manager with 20% gain this year sees good times ahead as FDA becomes 'more accommodating'

  10. Teva Enhances Board of Directors as All Proposals Approved at Annual General Meeting of Shareholders

    Teva Enhances Board of Directors as All Proposals Approved at Annual General Meeting of Shareholders

12345

©2017 Morningstar Advisor. All right reserved.